Thioredoxin: an antioxidant, a therapeutic target and a possible biomarker
- PMID: 38942889
- PMCID: PMC11521983
- DOI: 10.1038/s41390-024-03370-6
Thioredoxin: an antioxidant, a therapeutic target and a possible biomarker
Conflict of interest statement
The authors declare no competing interests.
Figures
Comment on
-
The serum thioredoxin-1 levels are not associated with bronchopulmonary dysplasia and retinopathy of prematurity.Pediatr Res. 2024 Oct;96(5):1275-1282. doi: 10.1038/s41390-024-03078-7. Epub 2024 Feb 16. Pediatr Res. 2024. PMID: 38365875 Free PMC article.
References
-
- Smith, C. V., Hansen, T. N., Martin, N. E., McMicken, H. W. & Elliott, S. J. Oxidant stress responses in premature infants during exposure to hyperoxia. Pediatr. Res. 34, 360–365 (1993). - PubMed
-
- Rajendran, P. et al. Antioxidants and human diseases. Clin. Chim. Acta436, 332–347 (2014). - PubMed
-
- Arnér, E. S. & Holmgren, A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem.267, 6102–6109 (2000). - PubMed
-
- Asikainen, T. M. & White, C. W. Antioxidant defenses in the preterm lung: role for hypoxia-inducible factors in BPD? Toxicol. Appl Pharm.203, 177–188 (2005). - PubMed
-
- Lu, J. & Holmgren, A. The thioredoxin antioxidant system. Free Radic. Biol. Med.66, 75–87 (2014). - PubMed
Publication types
LinkOut - more resources
Full Text Sources
